tv.qiagenbioinformatics.com marketingbiox@qiagen.com https://tv.qiagenbioinformatics.com Watch tutorials, interviews and much more on our web based TV channel! en-us Visualplatform http://blogs.law.harvard.edu/tech/rss tv.qiagenbioinformatics.com CLC bio TV Watch tutorials, interviews and much more on our web based TV channel! clc bio tv, bioinformatics, genomics, research episodic no https://tv.qiagenbioinformatics.com/files/rv0.0/sitelogo.gif https://tv.qiagenbioinformatics.com http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights <p><p>Cancer care has been transformed by comprehensive molecular profiling and targeted therapies&nbsp;– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.</p><p>That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:</p><ul><li><p>Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.</p></li><li><p>Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.</p></li><li><p>Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time.</p></li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights"><img src="http://tv.qiagenbioinformatics.com/64968576/117848531/329b5bafc47160923a30b713e075904a/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/117848531 Tue, 28 Oct 2025 14:27:49 GMT Deliver Clinical Molecular Insights at Scale with QCI Precision Insights Cancer care has been transformed by comprehensive molecular profiling and targeted therapies– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time. Cancer care has been transformed by comprehensive molecular profiling and targeted therapies– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from... tv.qiagenbioinformatics.com 51:33 <p><p>Cancer care has been transformed by comprehensive molecular profiling and targeted therapies&nbsp;– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.</p><p>That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:</p><ul><li><p>Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.</p></li><li><p>Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.</p></li><li><p>Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time.</p></li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights"><img src="http://tv.qiagenbioinformatics.com/64968576/117848531/329b5bafc47160923a30b713e075904a/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> qci http://tv.qiagenbioinformatics.com/photo/103634342/the-implementation-journey-of <p>This session traces the evolution of comprehensive cancer genome profiling (CGP) and liquid biopsy techniques in South East Asia, discussing the initial hurdles and ultimate triumphs. It details how interventions like international collaborations, technological enhancements, and policy support have enabled these advanced diagnostic tools' successful adoption. Highlighting the critical role of liquid biopsy in early cancer detection and monitoring treatment efficacy, the study underscores the importance of continued genomics research and investment for improved cancer care globally. It illustrates that, despite significant challenges, integrating advanced genomic profiling into oncology practice is attainable and transformative.</p><p><a href="http://tv.qiagenbioinformatics.com/photo/103634342/the-implementation-journey-of"><img src="http://tv.qiagenbioinformatics.com/64968580/103634342/d362dcd4d811b73eb5b0ec49f83ba161/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/103634342 Fri, 16 Aug 2024 13:29:53 GMT The Implementation Journey of Comprehensive Cancer Genome Profiling and... This session traces the evolution of comprehensive cancer genome profiling (CGP) and liquid biopsy techniques in South East Asia, discussing the initial hurdles and ultimate triumphs. It details how interventions like international collaborations, technological enhancements, and policy support have enabled these advanced diagnostic tools' successful adoption. Highlighting the critical role of liquid biopsy in early cancer detection and monitoring treatment efficacy, the study underscores the importance of continued genomics research and investment for improved cancer care globally. It illustrates that, despite significant challenges, integrating advanced genomic profiling into oncology practice is attainable and transformative. This session traces the evolution of comprehensive cancer genome profiling (CGP) and liquid biopsy techniques in South East Asia, discussing the initial hurdles and ultimate triumphs. It details how interventions like international collaborations,... tv.qiagenbioinformatics.com 01:02:58 <p>This session traces the evolution of comprehensive cancer genome profiling (CGP) and liquid biopsy techniques in South East Asia, discussing the initial hurdles and ultimate triumphs. It details how interventions like international collaborations, technological enhancements, and policy support have enabled these advanced diagnostic tools' successful adoption. Highlighting the critical role of liquid biopsy in early cancer detection and monitoring treatment efficacy, the study underscores the importance of continued genomics research and investment for improved cancer care globally. It illustrates that, despite significant challenges, integrating advanced genomic profiling into oncology practice is attainable and transformative.</p><p><a href="http://tv.qiagenbioinformatics.com/photo/103634342/the-implementation-journey-of"><img src="http://tv.qiagenbioinformatics.com/64968580/103634342/d362dcd4d811b73eb5b0ec49f83ba161/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> genome qci